Analgesics in the United Arab Emirates
- ID: 2477301
- June 2015
- Region: United Arab Emirates
- 27 pages
- Euromonitor International
Analgesics saw 7% current value growth in 2014, which was similar to the current value CAGR of 6% recorded over the review period. Analgesics is an OTC consumer health category which is entering maturity, although it continues to record healthy growth due to the rising population and tourist flows into the country.
The Analgesics in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
ANALGESICS IN THE UNITED ARAB EMIRATES
LIST OF CONTENTS AND TABLES
Table 1 Sales of Analgesics by Category: Value 2009-2014
Table 2 Sales of Analgesics by Category: % Value Growth 2009-2014
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2009-2014
Table 4 NBO Company Shares of Analgesics: % Value 2010-2014
Table 5 LBN Brand Shares of Analgesics: % Value 2011-2014
Table 6 Forecast Sales of Analgesics by Category: Value 2014-2019
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2014-2019
Julphar Gulf Pharmaceuticals in Consumer Health (united Arab Emirates)
Summary 1 Julphar Gulf Pharmaceutical: Operational Indicators
Summary 2 Julphar Gulf Pharmaceutical: Competitive Position 2014
Healthy Growth Continues in Consumer Health in the United Arab Emirates in 2014
Forecast Value Growth Is Threatened by GCC Price Harmonisation Initiative
the Strong Consumer Preference for Branded Products Is Difficult To Change
Chemists/pharmacies Continues To Lose Share
Strong Demand for Rx Products Poses A Threat To Demand for OTC Medicines
Key Trends and Developments
OTC Products Sees Healthy Growth in 2014, Driven by Growing Awareness of and Interest in Consumer Health
Raising Awareness of the Country's Rising Obesity Problem Is One of the Key Aims of the Government
GCC Price Harmonisation Impacts Development
Doctors Are Frequently Bypassed, As Patients Seek Advice From Pharmacists Or "dr Google"
50+ Age Group Becomes the Major Target of Marketing Campaigns for Vitamins and Dietary Supplements
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 9 Life Expectancy at Birth 2009-2014
Table 10 Sales of Consumer Health by Category: Value 2009-2014
Table 11 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 12 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 13 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 3 Research Sources